[go: up one dir, main page]

FI20040255L - Method for detecting the risk of pre-eclampsia - Google Patents

Method for detecting the risk of pre-eclampsia Download PDF

Info

Publication number
FI20040255L
FI20040255L FI20040255A FI20040255A FI20040255L FI 20040255 L FI20040255 L FI 20040255L FI 20040255 A FI20040255 A FI 20040255A FI 20040255 A FI20040255 A FI 20040255A FI 20040255 L FI20040255 L FI 20040255L
Authority
FI
Finland
Prior art keywords
detecting
risk
eclampsia
preeclampsia
kit
Prior art date
Application number
FI20040255A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI20040255A7 (en
FI20040255A0 (en
Inventor
Jukka Salonen
Mia Pirskanen
Pekka Uimari
Tomi-Pekka Tuomainen
Seppo Heinonen
Original Assignee
Jurilab Ltd Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jurilab Ltd Oy filed Critical Jurilab Ltd Oy
Priority to FI20040255A priority Critical patent/FI20040255A7/en
Publication of FI20040255A0 publication Critical patent/FI20040255A0/en
Priority to PCT/FI2005/050037 priority patent/WO2005078128A1/en
Publication of FI20040255L publication Critical patent/FI20040255L/en
Publication of FI20040255A7 publication Critical patent/FI20040255A7/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention provides a method and kit for detecting or diagnosing a risk of or predisposition to preeclampsia in a subject, the method comprising the steps of providing a biological sample taken from the subject to be tested and detecting the presence or absence of a variant genotype of a dimethylarginine dimethylaminohydrolase (DDAH) gene in the biological sample. The invention further provides a kit comprising means to carry out the method of the invention and a method for treatment and prevention of preeclampsia.
FI20040255A 2004-02-18 2004-02-18 Method for detecting the risk of pre-eclampsia FI20040255A7 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FI20040255A FI20040255A7 (en) 2004-02-18 2004-02-18 Method for detecting the risk of pre-eclampsia
PCT/FI2005/050037 WO2005078128A1 (en) 2004-02-18 2005-02-17 Method for detecting the risk of preeclampsia by analysing a dimethylarginine dimethylaminohydrolase gene

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20040255A FI20040255A7 (en) 2004-02-18 2004-02-18 Method for detecting the risk of pre-eclampsia

Publications (3)

Publication Number Publication Date
FI20040255A0 FI20040255A0 (en) 2004-02-18
FI20040255L true FI20040255L (en) 2005-08-19
FI20040255A7 FI20040255A7 (en) 2005-08-19

Family

ID=31725731

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20040255A FI20040255A7 (en) 2004-02-18 2004-02-18 Method for detecting the risk of pre-eclampsia

Country Status (2)

Country Link
FI (1) FI20040255A7 (en)
WO (1) WO2005078128A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111166274B (en) 2013-10-24 2025-01-28 奥瑞斯健康公司 Robotic-assisted endoluminal surgical system and related methods
CN106755492B (en) * 2017-01-24 2020-04-21 深圳金蕊科技有限公司 Complete set of SNP (Single nucleotide polymorphism) for predicting preeclampsia and application thereof
AU2018243364B2 (en) 2017-03-31 2023-10-05 Auris Health, Inc. Robotic systems for navigation of luminal networks that compensate for physiological noise
US10022192B1 (en) 2017-06-23 2018-07-17 Auris Health, Inc. Automatically-initialized robotic systems for navigation of luminal networks
US10426559B2 (en) 2017-06-30 2019-10-01 Auris Health, Inc. Systems and methods for medical instrument compression compensation
CN110831536B (en) 2017-12-06 2021-09-07 奥瑞斯健康公司 System and method for correcting for uncommanded instrument roll
EP4021329B1 (en) 2019-08-30 2025-12-10 Auris Health, Inc. Instrument image reliability systems and methods
WO2021137072A1 (en) 2019-12-31 2021-07-08 Auris Health, Inc. Anatomical feature identification and targeting
US11660147B2 (en) 2019-12-31 2023-05-30 Auris Health, Inc. Alignment techniques for percutaneous access
JP7497440B2 (en) 2019-12-31 2024-06-10 オーリス ヘルス インコーポレイテッド Alignment Interface for Percutaneous Access
US11737663B2 (en) 2020-03-30 2023-08-29 Auris Health, Inc. Target anatomical feature localization
CN113223714B (en) * 2021-05-11 2022-07-05 吉林大学 A gene combination for predicting preeclampsia risk, preeclampsia risk prediction model and construction method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2438740A1 (en) * 2001-02-16 2002-08-29 Incyte Genomics, Inc. Drug metabolizing enzymes
US20040214264A1 (en) * 2002-04-19 2004-10-28 Veli-Pekka Valkonen Nucleic acid molecule encoding a variant DDAH 1 protein and uses thereof
FI115532B (en) * 2002-10-07 2005-05-31 Jurilab Ltd Oy Procedure for detecting the risk of cardiovascular disease

Also Published As

Publication number Publication date
WO2005078128A1 (en) 2005-08-25
FI20040255A7 (en) 2005-08-19
FI20040255A0 (en) 2004-02-18

Similar Documents

Publication Publication Date Title
FI20040255L (en) Method for detecting the risk of pre-eclampsia
WO2007103374A3 (en) Toxicity screening methods
FI20050011A7 (en) Method and test kit for detecting the risk of type 2 diabetes mellitus
PL2126586T3 (en) Direct determination of vitamin d in serum or plasma
WO2008084409A3 (en) Means for identifying a strain isolated from a clinical sample at the species and/or subspecies level
DE602007004771D1 (en) Method for quantitative cDNA analysis in single cells
WO2008114282A3 (en) Transgenic rice (oryza sativa) comprising pe-7 event and method of detection thereof
SI1871901T1 (en) Elite event a5547-127 and methods and kits for identifying such event in biological samples
DK1883474T3 (en) SYSTEM FOR INTEGRATED AND AUTOMATED DNA OR PROTEIN ANALYSIS AND METHOD FOR OPERATING SUCH A SYSTEM
WO2008060651A3 (en) Sparc and methods of use thereof
DE602004030054D1 (en) Apparatus for testing biological samples and chemical samples
WO2006047787A3 (en) Method for monitoring disease progression or recurrence
ES2364314T8 (en) DETECTION AND PREACHING PREECLAMPSY.
ATE474228T1 (en) REAGENT FOR HEMOGLOBINA DEGRADATION
DE602005009094D1 (en) Method for waiting time analysis for dynamic states in the complex discrete production
WO2010061283A8 (en) Biomarkers for diagnosing and detecting the progression of neurodegenerative disorders, in particular of amyotrophic lateral sclerosis
WO2006028601A3 (en) Method for distinguishing methicillin resistant s. aureus from methicillin sensitive s. aureus in a mixed culture
WO2006113245A3 (en) Methods for measuring glycan levels of proteins
WO2009014987A3 (en) Identification and quantification of biomarkers for evaluating the risk of preterm birth
WO2004058051A3 (en) Androgen-regulated genes and uses for diagnosis, prognosis and treatment of prostate neoplastic conditions
WO2007030949A3 (en) Methods of diagnosing ovarian cancer and kits therefor
WO2008145701A9 (en) Method for predicting the outcome of a critically ill patient
WO2006092729A3 (en) Novel biomarkers for diagnosis and/or prognosis or prognosis of neoplasias in animals
NZ551782A (en) Agents and methods for diagnosing stress
WO2013077814A3 (en) Natural-killer/t-cell lymphoma (nktcl) susceptibility prediction, diagnosis and therapy

Legal Events

Date Code Title Description
FD Application lapsed